Srivatsan Ramesh, Ph.D.Process Development Scientist at BridgeBio Gene TherapySpeaker
Profile
Srivatsan Ramesh is a process development scientist at BridgeBio with more than three years of bioprocessing experience, advancing various programs from early research through late-stage development, including leading process validation studies, and pivotal/BLA-enabling studies. He has a proven track record in designing development studies, leading tech transfers to CDMOs, and overseeing GMP manufacturing to support clinical and regulatory milestones. He holds a Ph.D. in Chemical and Biomolecular Engineering from North Carolina State University.
Agenda Sessions
Ensuring Viral Safety in AAV9 Gene Therapy Program: Potentially Platformable Approach that Delivers Robust Clearance
, 2:30pmView Session
